Sarcopenia as a Risk Factor in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt (TIPS) Implantation
<b>Background</b>: Prior studies suggest that patients’ body composition changes following transjugular intrahepatic portosystemic shunt (TIPS) implantation, potentially influencing complications and survival. <b>Method</b>: A prototype artificial intelligence (AI)-based, aut...
Saved in:
| Main Authors: | Laura Büttner, Annette Aigner, Regina Stegherr, Simon Iseke, Martin Jonczyk, Willie Magnus Lüdemann, Timo Alexander Auer, Federico Collettini, Dirk Schnapauff, Maximilian de Bucourt, Bernhard Gebauer, Dominik Geisel, Georg Böning |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Diagnostics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4418/15/11/1440 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Transjugular Intrahepatic Portosystemic Shunt Reduction for Medically Refractory Hepatic Encephalopathy
by: Brandon Toliver, et al.
Published: (2024-08-01) -
Transjugular intrahepatic portosystemic shunt for the treatment of portal hypertension complications: A single-center retrospective cohort
by: Jianbin Zhang, MD, et al.
Published: (2025-01-01) -
Transjugular Intrahepatic Portosystemic Shunt (TIPS): bridging the gap from bench to bedside
by: Citra Indriani Sibarani, et al.
Published: (2025-06-01) -
Transjugular intrahepatic portosystemic shunt: a meta-analysis of 8 mm versus 10 mm stents
by: Ping-Chao Huang, et al.
Published: (2021-03-01) -
Decreasing systemic inflammation after TIPS: Still hope for the liver: Reply to correspondence on “Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis”
by: Georg Semmler, et al.
Published: (2025-04-01)